Shining a Light: Understanding the Complexities of Rare Diseases and Orphan Drug Development
Rare Disease Day will take place on February 29th this year and is a global opportunity to raise awareness for the individuals and families facing...
Rare Disease Day will take place on February 29th this year and is a global opportunity to raise awareness for the individuals and families facing...
In the ever-evolving landscape of healthcare, a challenge persists – the unequal distribution, access, and quality of care for individuals. In...
Therapeutic innovation drives patient treatment updates and improves patient outcomes. From the development of chemotherapy to monoclonal antibody...
Payors are major stakeholders in the US healthcare system and shape patient access, health spending, and reimbursement. In this blog post, we will...
Beyond reviewing and approving drugs, the FDA plays a pivotal role in overseeing and approving medical devices, a realm defined by its innovation,...
In today's fast-paced world, where information overload is the norm, the need for evidence-based decision-making has never been greater. Systematic...
Let's face it, the healthcare landscape is complex - developing clear and concise value communication across stakeholders is essential.
Inflation affects nearly all goods and services on the market, including drugs and healthcare products. This is the first of a series of posts...
We are PFG MedComm, a market access and medical communication strategic consultancy. The medical industry is filled with complex ideas that can be...